The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Galenea wins $4.5M NIH grant

October 17, 2010 4:32 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Cambridge biopharmaceutical firm Galenea Corp. has won a $4.5 million grant from the National Institute of Mental Health for a technology platform aimed at identifying compounds to treat schizophrenia.


Generex Announces Approval of Adjournment Proposal and Adjourned Special Meeting Date

October 17, 2010 3:32 am | by Bio-Medicine.Org | News | Comments

WORCESTER, Mass., Oct. 15 /- Generex Biotechnology Corporation (Nasdaq: GNBT, ) today announced that it reconvened a special meeting of stockholders (the "Special Meeting") on October 15, 2010 at 10:00 a.m. (local time) at the Meeting Rooms, Westin Harbour Castle Hotel, 1...


New Online Pharmacy is Launched by One of the Leading Pharmaceutical Companies, Rx Corp

October 17, 2010 3:31 am | by Bio-Medicine.Org | News | Comments

MEMPHIS, Tenn., Oct. 17 /- The new online pharmacy was launched after the company had studied the market of pharmaceuticals, coming to the conclusion there are not enough reliable and trustworthy places to shop for high quality prescription medications. With the many years of experience...


Long-Term Data Show Novartis Once-Yearly Reclast Preserves Bone Mass and Provides Fracture Protection in Postmenopausal Osteoporosis

October 16, 2010 4:31 pm | by Bio-Medicine.Org | News | Comments

EAST HANOVER, N.J., Oct. 16 /- Novartis announced today that new six-year data reinforce the long-term efficacy and safety profile of once-yearly Reclast® (zoledronic acid) injection in postmenopausal women with osteoporosis.(1) The study of more than 1,200 women was presented this...


ISTA Pharmaceuticals Receives FDA Approval for BROMDAY™

October 16, 2010 10:32 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Oct. 16 /- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA ), today announced the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental New Drug Application (sNDA) for BROMDAY™ (bromfenac ophthalmic solution) 0.09% as a once-daily prescription eye...


Medical Device Conference Opens October 18, 2010 With Free Executive Workshops; Full Conference Highlights Latest Industry Trends, Technology Innovations and Keynote Speeches ...

October 16, 2010 10:31 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Oct. 16 /PRNewswire-USNewswire/ -- AdvaMed 2010 : The MedTech Conference opens on Monday, October 18 with a series of free educational Executive Workshops focused on bringing products to the US markets, a 1/2 day entrepreneur bootcamp, and minimizing risk and global...


Acute Cardiac Care 2010

October 16, 2010 12:31 am | by EurekAlert | News | Comments

(European Society of Cardiology) Today in most countries of the world almost 50 percent of patients in hospital for a cardiac condition began their treatment as emergency cases: chest pain at home or cardiac arrest in the street.


Excelsior Medical 5 ml Fill in 6 cc Prefilled Saline Flush Syringes: Recall - Potential Loss of Sterility

October 15, 2010 12:31 pm | by U.S. Food & Drug Administration | News | Comments

Exposure to syringes with a sterility issue could result in systemic infection, which may lead to serious injury and/or death.


Sun Healthcare spinoff to offer $225M in notes

October 15, 2010 11:45 am | by The Associated Press | News | Comments

Health care facility operator Sun Healthcare Group Inc. said Friday that its spinoff company Sabra Health Care REIT Inc. plans to offer $225 million in senior notes due 2018 in a private offering.Sun Healthcare is separating into two separate companies. Sabra Health Care will own all of the...

CareFusion Corporation Alaris PC Units (Model 8015): Recall - Potential for Delay or Interruption of Therapy

October 15, 2010 11:30 am | by U.S. Food & Drug Administration | News | Comments

Hardware communication error may lead to serious injury or death.


Medtronic gets OK to study heart valve in US

October 15, 2010 10:45 am | by The Associated Press | News | Comments

Medtronic Inc., the world's largest medical device maker, said Friday it received U.S. regulatory approval to begin testing a new artificial heart valve that can be implanted with minimal surgery.The company said the Food and Drug Administration gave clearance to study the company's CoreValve...

Methodist Mansfield Medical Center Donates 4,000 Pedometers for Entire Mansfield ISD Staff

October 15, 2010 10:32 am | by Bio-Medicine.Org | News | Comments

MANSFIELD, Texas, Oct. 15 /- Methodist Mansfield Medical Center will provide a pedometer to every staff member of the Mansfield Independent School District as well as sponsor a Principals' Fitness Challenge program to promote the importance of health and fitness. By helping principals and...


Isis Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference

October 15, 2010 10:31 am | by Bio-Medicine.Org | News | Comments

CARLSBAD, Calif., Oct. 15 /- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader in antisense therapeutics, today announced that management will present a company overview at the 17th Annual NewsMakers in the Biotech Industry Conference on Friday, October 22, 2010 at 11:00 a.m. ET at...


CareFusion Recall of Alaris PC Units Model 8015 Classified as Class I Recall

October 15, 2010 8:36 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Oct. 15 /- CareFusion (NYSE: CFN ), a leading, global medical device company, issued the following update regarding its previously disclosed recall of approximately 17,000 Alaris® PC units model 8015 manufactured or serviced between December 2008 and September 2009. The...


Regeneron Announces Presentation at the 17th Annual NewsMakers in the Biotech Industry Conference

October 15, 2010 8:35 am | by Bio-Medicine.Org | News | Comments

TARRYTOWN, N.Y., Oct. 15 /- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) will webcast its presentation at the 17th Annual NewsMakers in the Biotech Industry Conference on Friday, October 22, 2010.  The presentation is scheduled for 9:00 a.m. Eastern Time.  The session may be...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.